Control Bionics Limited (ASX:CBL) has requested a trading halt in accordance with Listing Rule 17.1. The halt is pending the finalization of terms for a proposed placement and subsequent rights issue. The company aims to lift the trading halt by the commencement of trade on Monday, 23 September 2024.
The trading halt has been requested to ensure that the market is properly informed about the proposed placement and rights issue. We have approached several parties in this regard and believe that the announcement of the placement by Monday 23 September 2024 will allow for the trading halt to be lifted. We are not aware of any reasons why the trading halt should not be granted.
Control Bionics Limited (ASX:CBL) has requested a trading halt pending the finalization of terms for a proposed placement and subsequent rights issue. The company aims to lift the trading halt by the commencement of trade on Monday, 23 September 2024. The Chairman, Roger Hawke, emphasized the importance of ensuring proper market information and expressed confidence in lifting the halt upon the announcement of the placement. The company is not aware of any reasons why the trading halt should not be granted.